Paper3971375
A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice.
Sekine K and 5 others. Cancer Res, 1985. Cited by 105 papers, by iCite.
Cite this record
ConductScience Library. A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice. Papers, record 3971375. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3971375
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Bifidobacterium | Major topic |
| Neoplasms, Experimental | Major topic |
| Peptidoglycan | Major topic |
| Animals | |
| Cell Wall | |
| In Vitro Techniques | |
| Male | |
| Mice | |
| Mice, Inbred BALB C |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT04046432 | Effects of Vigiis 101-LAB on a Healthy Populations' Gut Microflora, Peristalsis, Immunity, and Anti-oxidative Capacity | Results | ClinicalTrials.gov | |
| NCT04088474 | Effects of Vigiis 101-LAB on a Healthy Populations' Gut Microflora | Results | ClinicalTrials.gov |
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 105 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41917413 | The Sizes and Shapes of Glycan-Presenting Particles Determine IL-12 Production from Mononuclear Phagocytes via a Glycan-Dependent Phagocytic Process. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/41917413 | PubMed |
| 40607403 | Peptidoglycan derived from Lacticaseibacillus rhamnosus and Lactobacillus acidophilus suppress TLR2/1-mediated inflammation in bovine endometrial epithelial cells. | Front Immunol | 2025 | https://conductscience.org/library/papers/40607403 | PubMed |
| 39796098 | Structural Characterization and Immune Activation Capacity of Peptidoglycan from Corynebacterium glutamicum in RAW264.7 Cells. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39796098 | PubMed |
| 39481288 | Development and mechanism exploration of a quantitative model for Escherichia coli transformation efficiency based on ultrasonic power. | Ultrason Sonochem | 2024 | https://conductscience.org/library/papers/39481288 | PubMed |
| 39339770 | Yoyo Dieting, Post-Obesity Weight Loss, and Their Relationship with Gut Health. | Nutrients | 2024 | https://conductscience.org/library/papers/39339770 | PubMed |
| 39338524 | Identification of Bioactive Substances Derived from the Probiotic-Induced Bioconversion of Lagerstroemia speciosa Pers. Leaf Extract That Have Beneficial Effects on Diabetes and Obesity. | Microorganisms | 2024 | https://conductscience.org/library/papers/39338524 | PubMed |
| 38375206 | Loss of symbiotic and increase of virulent bacteria through microbial networks in Lynch syndrome colon carcinogenesis. | Front Oncol | 2023 | https://conductscience.org/library/papers/38375206 | PubMed |
| 36144335 | Do Bacteria Provide an Alternative to Cancer Treatment and What Role Does Lactic Acid Bacteria Play? | Microorganisms | 2022 | https://conductscience.org/library/papers/36144335 | PubMed |
| 36101996 | The effect of <em>Lactobacillus casei</em> and <em>Bacillus coagulans</em> probiotics on liver damage induced by silver nanoparticles and expression of Bax, Bcl2 and Caspase 3 genes in male rats. | Eur J Transl Myol | 2022 | https://conductscience.org/library/papers/36101996 | PubMed |
| 36016797 | Wall teichoic acid-dependent phagocytosis of intact cell walls of Lactiplantibacillus plantarum elicits IL-12 secretion from macrophages. | Front Microbiol | 2022 | https://conductscience.org/library/papers/36016797 | PubMed |
| 35603970 | Probiotic Engineering and Targeted Sonoimmuno-Therapy Augmented by STING Agonist. | Adv Sci (Weinh) | 2022 | https://conductscience.org/library/papers/35603970 | PubMed |
| 34721321 | Anti-cancer Substances and Safety of Lactic Acid Bacteria in Clinical Treatment. | Front Microbiol | 2021 | https://conductscience.org/library/papers/34721321 | PubMed |
| 34030655 | The metabolic profile of Bifidobacterium dentium reflects its status as a human gut commensal. | BMC Microbiol | 2021 | https://conductscience.org/library/papers/34030655 | PubMed |
| 33603997 | Anti-proliferative effects of cell wall, cytoplasmic extract of Lactococcus lactis and nisin through down-regulation of cyclin D1 on SW480 colorectal cancer cell line. | Iran J Microbiol | 2020 | https://conductscience.org/library/papers/33603997 | PubMed |
| 32995642 | Effects of Vigiis 101-LAB on a healthy population's gut microflora, peristalsis, immunity, and anti-oxidative capacity: A randomized, double-blind, placebo-controlled clinical study. | Heliyon | 2020 | https://conductscience.org/library/papers/32995642 | PubMed |
| 32819443 | Postbiotics-parabiotics: the new horizons in microbial biotherapy and functional foods. | Microb Cell Fact | 2020 | https://conductscience.org/library/papers/32819443 | PubMed |
| 31648597 | Double deletion of murA and murB induced temperature sensitivity in Corynebacterium glutamicum. | Bioengineered | 2019 | https://conductscience.org/library/papers/31648597 | PubMed |
| 31213556 | Bifidobacterium dentium Fortifies the Intestinal Mucus Layer via Autophagy and Calcium Signaling Pathways. | mBio | 2019 | https://conductscience.org/library/papers/31213556 | PubMed |
| 30410487 | Vaginal Lactobacilli Induce Differentiation of Monocytic Precursors Toward Langerhans-like Cells: in Vitro Evidence. | Front Immunol | 2018 | https://conductscience.org/library/papers/30410487 | PubMed |
| 29963126 | Antitumor mechanisms of bifidobacteria. | Oncol Lett | 2018 | https://conductscience.org/library/papers/29963126 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3971375
GET https://conductscience.org/api/papers/v1/3971375/cited_by?page=2